Everything that I have read, other than this article bit from Reuters, mentioned Hikma’s 180-day protection. The only thing I can think of is whether other shipments are for outside US, but FDA doesn’t dictate approval in other countries, but rather can sometimes validate. Don’t have time to dig further this weekend. Could be misreporting, but would find that out of character for Reuters.